Q2 2015 Holdings
Filed 2015-08-14 | 55 holdings | $104.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV) | COM | 00287Y109 | $34.3M | 510,010 | 32.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $32.0M | 79,118 | 30.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $28.4M | 207,744 | 27.3% |
| Cerus Corp(CERS) | COM | 157085101 | $8.3M | 1,603,427 | 8.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $98.2K | 13,623,620 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $89.1K | 6,297,523 | 0.1% |
| Valeant Pharmaceuticals Intl | COM | 91911K102 | $85.4K | 384,506 | 0.1% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $66.7K | 759,479 | 0.1% |
| Teva Pharmaceutical Inds LTD(TEVA) | ADR | 881624209 | $57.2K | 967,359 | 0.1% |
| Allergan PLC | SHS | G0177J108 | $41.5K | 136,818 | 0.0% |
| Kythera Biopharmaceuticals I | COM | 501570105 | $36.3K | 482,556 | 0.0% |
| HCA Holdings Inc(HCA) | COM | 40412C101 | $35.4K | 390,000 | 0.0% |
| Aetna Inc New | COM | 00817Y108 | $33.7K | 264,075 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $32.3K | 699,425 | 0.0% |
| Cigna Corporation | COM | 125509109 | $32.2K | 198,700 | 0.0% |
| Receptos Inc | COM | 756207106 | $27.4K | 144,205 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $26.6K | 150,866 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $25.6K | 529,199 | 0.0% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $25.0K | 175,965 | 0.0% |
| Health NET Inc | COM | 42222G108 | $24.9K | 388,128 | 0.0% |
| Alere Inc | COM | 01449J105 | $24.3K | 461,170 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $22.5K | 1,459,742 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $21.2K | 290,350 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $21.2K | 867,346 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $19.7K | 372,642 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $19.5K | 610,171 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $17.9K | 146,027 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $17.2K | 164,995 | 0.0% |
| Model N Inc(MODNEUR) | COM | 607525102 | $17.2K | 1,443,278 | 0.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $16.8K | 1,212,892 | 0.0% |
| Castlight Health Inc(CSLT1EUR) | CL B | 14862Q100 | $16.2K | 1,984,631 | 0.0% |
| ZS Pharma Inc | COM | 98979G105 | $15.9K | 302,988 | 0.0% |
| Oncothyreon Inc | COM | 682324108 | $15.6K | 4,164,878 | 0.0% |
| Civitas Solutions Inc | COM | 17887R102 | $14.0K | 657,693 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $13.0K | 2,007,446 | 0.0% |
| Davita Healthcare Partners I(DVA) | COM | 23918K108 | $11.1K | 140,191 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $9.7K | 378,235 | 0.0% |
| Avalanche Biotechnologies in | COM | 05337G107 | $8.7K | 537,282 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $8.6K | 516,690 | 0.0% |
| Genocea Biosciences Inc | COM | 372427104 | $8.6K | 623,519 | 0.0% |
| Fluidigm Corp del(LAB) | COM | 34385P108 | $8.4K | 348,237 | 0.0% |
| Trivascular Technologies Inc | COM | 89685A102 | $7.8K | 1,464,563 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $7.0K | 152,700 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $6.9K | 67,425 | 0.0% |
| Bellicum Pharmaceuticals Inc | COM | 079481107 | $5.1K | 238,121 | 0.0% |
| Array Biopharma Inc | NOTE 3.000% 6/0 | 04269XAA3 | $5.1K | $4,000,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $3.9K | 476,293 | 0.0% |
| Eleven Biotherapeutics Inc | COM | 286221106 | $3.6K | 1,261,260 | 0.0% |
| Flexion Therapeutics Inc | COM | 33938J106 | $3.1K | 142,483 | 0.0% |
| Axovant Sciences LTD | COM | G0750W104 | $3.1K | 150,000 | 0.0% |